CN Patent

CN120574152A — (r)-2-氨基-3-苯丙基氨基甲酸酯盐酸盐的溶剂化物形式的晶体、其制备方法、组合物及用途

Assigned to Gaz Pharmaceutical Co ltd · Expires 2025-09-02 · 1y expired

What this patent protects

本申请涉及(R)‑2‑氨基‑3‑苯丙基氨基甲酸酯盐酸盐的溶剂化物形式的晶体、其制备方法、组合物及用途。本发明涉及新发现的(R)‑2‑氨基‑3‑苯丙基氨基甲酸酯(APC)盐酸盐的溶剂化物形式、APC盐酸盐的制备方法以及将其用于障碍治疗的方法。本发明还涉及以提高的纯度制备APC盐酸盐的方法。

USPTO Abstract

本申请涉及(R)‑2‑氨基‑3‑苯丙基氨基甲酸酯盐酸盐的溶剂化物形式的晶体、其制备方法、组合物及用途。本发明涉及新发现的(R)‑2‑氨基‑3‑苯丙基氨基甲酸酯(APC)盐酸盐的溶剂化物形式、APC盐酸盐的制备方法以及将其用于障碍治疗的方法。本发明还涉及以提高的纯度制备APC盐酸盐的方法。

Drugs covered by this patent

solriamfetol-hydrochloride (SOLRIAMFETOL HYDROCHLORIDE)

Patent Metadata

Patent number: CN120574152A
Jurisdiction: CN
Classification: —
Expires: 2025-09-02
Drug substance claim: No
Drug product claim: No
Assignee: Gaz Pharmaceutical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.